FDG Accumulation and Tumor Biology

Appleman, 1989, Kinetics of the purified glucose transporter, Biochemistry, 28, 8221, 10.1021/bi00446a038 Arora, 1990, Glucose phosphorylation in tumor cells, J. Biol. Chem., 265, 6481, 10.1016/S0021-9258(19)39352-4 Baldwin, 1995, Trafficking of glucose transporters—signals and mechanisms, Biosci. Rep., 15, 419, 10.1007/BF01204346 Bell, 1993, Structure and function of mammalian facilitative sugar transporters, J. Biol. Chem., 268, 19161, 10.1016/S0021-9258(19)36489-0 Biersack, 1997, FDG-PET in clinical oncology, 1 Birnbaum, 1987, Transformation of rat fibroblasts by FSV rapidly increases glucose transporter gene transcription, Science, 235, 1495, 10.1126/science.3029870 Bourne, 1990, The GTPase superfamily, Nature, 348, 125, 10.1038/348125a0 Brock, 1997, Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology?, Eur. J. Nucl. Med., 24, 691, 10.1007/BF00841411 Bustamante, 1981, Energy metabolism of tumor cells, J. Biol. Chem., 256, 8699, 10.1016/S0021-9258(19)68900-3 Carruthers, 1990, Facilitated diffusion of glucose, Physiol. Rev., 70, 1135, 10.1152/physrev.1990.70.4.1135 Cloherty, 1996, Human erythrocyte sugar transport is incompatible with available carrier models, Biochemistry, 35, 10411, 10.1021/bi953077m Conti, 1996, PET and [18F]-FDG in oncology, Nucl. Med. Biol., 23, 717, 10.1016/0969-8051(96)00074-1 Denissenko, 1996, Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hot spots in p53, Science, 274, 430, 10.1126/science.274.5286.430 el-Deiry, 1993, WAF1, a potential mediator of p53 tumor suppression, Cell, 75, 817, 10.1016/0092-8674(93)90500-P Fanciulli, 1994, Glycolysis and growth rate in normal and in hexokinase transfected NIH 3T3 cells, Oncol. Res., 6, 405 Fischman, 1993, FDG-PET in oncology, J. Nucl. Med., 34, 6 Flier, 1987, Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes, Science, 235, 1492, 10.1126/science.3103217 Gallagher, 1978, Metabolic trapping as a principle of radiopharmaceutical design, J. Nucl. Med., 19, 1154 Glebov, 1994, Frequent p53 gene mutations and novel alleles in familial breast cancer, Cancer Res., 54, 3703 Haberkorn, 1991, PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy, J. Nucl. Med., 32, 1485 Hamberg, 1994, The dose uptake ratio as an index of glucose metabolism, J. Nucl. Med., 35, 1308 Hatanaka, 1974, Transport of sugars in tumor cell membranes, Biochim. Biophys. Acta, 355, 77 Hiraki, 1988, Growth factors rapidly induce expression of the glucose transporter gene, J. Biol. Chem., 263, 13655, 10.1016/S0021-9258(18)68291-2 Inukai, 1995, Characterization of rat GLUT5 and functional analysis of chimeric proteins of GLUT1 glucose transporter and GLUT5 fructose transporter, Endocrinology, 136, 4850, 10.1210/en.136.11.4850 Karnik, 1994, Estrogen-receptor mutations in tamoxifen-resistant breast cancer, Cancer Res., 54, 349 Kubota, 1992, Intramural distribution of fluorine-18-fluorodeoxyglucose in vivo: High accumulation in macrophages and granulation tissue studies by microautoradiography, J. Nucl. Med., 33, 1972 Martineau, 1972, Enhancement of hexose entry into chick fibroblasts by starvation, Proc. Natl. Acad. Sci. U. S. A., 69, 3407, 10.1073/pnas.69.11.3407 Minn, 1996, Influence of hypoxia on tracer accumulation in squamous cell carcinoma, Nucl. Med. Biol., 23, 941, 10.1016/S0969-8051(96)00134-5 Monakhov, 1978, Physicochemical properties and isoenzyme composition of hexokinase from normal and malignant human tissues, J. Natl. Cancer Inst., 61, 27, 10.1093/jnci/61.1.27 Mueckler, 1985, Sequence and structure of a human glucose transporter, Science, 229, 941, 10.1126/science.3839598 Mueckler, 1995, Homeostasis without a GLUT, Nature, 377, 100, 10.1038/377100a0 Murakami, 1992, Type 1 glucose transporter from the mouse which are responsive to serum, growth factor, and oncogenes, J. Biol. Chem., 267, 9300, 10.1016/S0021-9258(19)50423-9 Nishioka, 1992, Distribution of glucose transporters in human brain tumors, Cancer Res., 52, 3972 Patronas, 1982, Work in progress, Radiology, 144, 885, 10.1148/radiology.144.4.6981123 Phelps, 1979, Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18) 2-fluoro-2-deoxy-d-glucose, Ann. Neurol., 6, 371, 10.1002/ana.410060502 Pulselli, 1996, Effect of lonidamine on the mitochondrial potential in situ in Ehrlich ascites tumor cells, Anticancer Res., 16, 419 Reivich, 1985, Glucose metabolic rate kinetic model parameter determination in humans, J. Cereb. Blood Flow Metab., 5, 179, 10.1038/jcbfm.1985.24 Rigo, 1996, Oncological applications of positron emmission tomography with fluorine-18 fluorodeoxyglucose, Eur. J. Nucl. Med., 23, 1641, 10.1007/BF01249629 Ruoslahti, 1994, Anchorage dependence, integrins and apoptosis, Cell, 77, 477, 10.1016/0092-8674(94)90209-7 Scheffzek, 1997, The ras-rasGAP complex, Science, 277, 333, 10.1126/science.277.5324.333 Schmidt, 1996, Fluorine-18-fluorodeoxyglucose PET to determine regional cerebral glucose utilisation, J. Nucl. Med., 37, 394 Schuier, 1990, Influence of plasma glucose concentration on lumped constant of the deoxyglucose method, J. Cereb. Blood Flow Metab., 10, 765, 10.1038/jcbfm.1990.134 Sokoloff, 1977, The [14-C]deoxyglucose method for the measurement of local cerebral glucose utilisation, J. Neurochem., 28, 897, 10.1111/j.1471-4159.1977.tb10649.x Som, 1980, A fluorinated glucose analog, 2-fluoro-2-deoxy-d-glucose (F-18), J. Nucl. Med., 21, 670 Strauss, 1996, Fluorine-18 deoxyglucose and false-positive results, Eur. J. Nucl. Med., 23, 1409, 10.1007/BF01367602 Su, 1990, Elevation of facilitated glucose transporter messenger RNA in human hepatocellular carcinoma, Hepatology, 11, 118, 10.1002/hep.1840110120 Wahl, 1991, Primary and metastatic breast carcinoma, Radiology, 179, 765, 10.1148/radiology.179.3.2027989 Warburg, 1925, Uber den Stoffwechsel der Carcinomzelle, Klin. Wochenschr. Berl., 4, 534, 10.1007/BF01726151 Warburg, 1956, On the origin of cancer cells, Science, 123, 309, 10.1126/science.123.3191.309 Weber, 1977, Enzymology of cancer cells (first of two parts), N. Engl. J. Med., 296, 486, 10.1056/NEJM197703032960905 Weber, 1977, Enzymology of cancer cells (second of two parts), N. Engl. J. Med., 296, 541, 10.1056/NEJM197703102961005 Wooster, 1995, Identification of the breast cancer susceptibility gene BRCA2, Nature, 378, 789, 10.1038/378789a0 Yamamoto, 1990, Over-expression of facilitative glucose transporter genes in human cancer, Biochem. Biophys. Res. Commun., 170, 223, 10.1016/0006-291X(90)91263-R Yonekura, 1982, Increased accumulation of 2-deoxy-2-[18F]-fluoro-d-glucose in liver metastases from colon carcinoma, J. Nucl. Med., 23, 1133